{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T23:26:50Z","timestamp":1774481210848,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005565","name":"Johnson &amp; Johnson Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.genhosppsych.2024.07.001","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T17:36:56Z","timestamp":1720114616000},"page":"62-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Blood pressure changes during ketamine infusion for the treatment of depression"],"prefix":"10.1016","volume":"90","author":[{"given":"Mina","family":"Ansari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Tylee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Ostroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel T.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Nikayin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.genhosppsych.2024.07.001_bb0005","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40263-021-00846-5","article-title":"Prevention and Management of Common Adverse Effects of ketamine and Esketamine in patients with mood disorders","volume":"35","author":"Ceban","year":"2021","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.genhosppsych.2024.07.001_bb0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data Meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.genhosppsych.2024.07.001_bb0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/ijnp\/pyab023","article-title":"Ketamine for bipolar depression: a systematic review","volume":"24","author":"Bahji","year":"2021","journal-title":"Int J Neuropsychopharmacol"},{"issue":"11","key":"10.1016\/j.genhosppsych.2024.07.001_bb0020","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1176\/ps.2009.60.11.1466","article-title":"The STAR*D trial: revealing the need for better treatments","volume":"60","author":"Insel","year":"2009","journal-title":"Psychiatr Serv"},{"issue":"25","key":"10.1016\/j.genhosppsych.2024.07.001_bb0025","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","article-title":"Ketamine versus ECT for nonpsychotic treatment-resistant major depression","volume":"388","author":"Anand","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2024.07.001_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2024.07.001_bb0035","first-page":"61","article-title":"Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia","volume":"39","author":"Haas","year":"1992","journal-title":"Anesth Prog"},{"key":"10.1016\/j.genhosppsych.2024.07.001_bb0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jad.2018.02.025","article-title":"Blood pressure safety of subanesthetic ketamine for depression: a report on 684 infusions","volume":"236","author":"Riva-Posse","year":"2018","journal-title":"J Affect Disord"},{"issue":"Suppl. 3","key":"10.1016\/j.genhosppsych.2024.07.001_bb0045","first-page":"585","article-title":"Short-term ketamine administration in treatment-resistant depression: focus on cardiovascular safety","volume":"31","author":"Szarmach","year":"2019","journal-title":"Psychiatr Danub"},{"issue":"3","key":"10.1016\/j.genhosppsych.2024.07.001_bb0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.13m08852","article-title":"Ketamine safety and tolerability in clinical trials for treatment-resistant depression","volume":"76","author":"Wan","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.genhosppsych.2024.07.001_bb0055","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s40263-020-00763-z","article-title":"The cardiovascular effects of newer antidepressants in older adults and those with or at high risk for cardiovascular diseases","volume":"34","author":"Behlke","year":"2020","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.genhosppsych.2024.07.001_bb0060","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.genhosppsych.2024.07.001_bb0065","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1176\/appi.ajp.2017.17020239","article-title":"A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders","volume":"174","author":"Wilkinson","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2024.07.001_bb0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/JCP.0000000000001542","article-title":"Vital sign changes during intravenous ketamine infusions for depression: an exploratory study of prognostic indications","volume":"42","author":"Keith","year":"2022","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"10.1016\/j.genhosppsych.2024.07.001_bb0075","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/ijnp\/pyx055","article-title":"Factors influencing the cardiovascular response to subanesthetic ketamine: a randomized","volume":"20","author":"Liebe","year":"2017","journal-title":"Placebo-Controlled Trial International Journal of Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.genhosppsych.2024.07.001_bb0080","first-page":"243","article-title":"Ketamine: a review for clinicians","volume":"16","author":"Sanacora","year":"2018","journal-title":"Focus (Am Psychiatr Publ)"},{"issue":"9","key":"10.1016\/j.genhosppsych.2024.07.001_bb0085","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jagp.2020.12.032","article-title":"Safety, tolerability, and real-world effectiveness of intravenous ketamine in older adults with treatment-resistant depression: a case series","volume":"29","author":"Lipsitz","year":"2021","journal-title":"Am J Geriatr Psychiatry"},{"issue":"8","key":"10.1016\/j.genhosppsych.2024.07.001_bb0090","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/14740338.2020.1776699","article-title":"Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence","volume":"19","author":"Rodrigues","year":"2020","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1016\/j.genhosppsych.2024.07.001_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0706743720970860","volume":"66","author":"Swainson","year":"2021","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2024.07.001_bb0100","doi-asserted-by":"crossref","first-page":"1017504","DOI":"10.3389\/fpsyt.2022.1017504","article-title":"Intravenous ketamine for depression: a clinical discussion reconsidering best practices in acute hypertension management","volume":"13","author":"Yip","year":"2022","journal-title":"Front Psych"},{"key":"10.1016\/j.genhosppsych.2024.07.001_bb0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00213-007-0706-2","article-title":"Psychiatric safety of ketamine in psychopharmacology research","volume":"192","author":"Perry","year":"2007","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.genhosppsych.2024.07.001_bb0110","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.biopsych.2012.02.039","article-title":"On the safety and benefits of repeated intravenous injections of ketamine for depression","volume":"72","author":"Blier","year":"2012","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.genhosppsych.2024.07.001_bb0115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4997\/jrcpe.2020.409","article-title":"Retrospective studies \u2013 utility and caveats","volume":"50","author":"Talari","year":"2020","journal-title":"J Royal Colleg Phys Edinburgh"},{"issue":"12","key":"10.1016\/j.genhosppsych.2024.07.001_bb0120","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3928\/00485713-20221123-01","article-title":"Racial disparities in access to psychedelic treatments and inclusion in research trials","volume":"52","author":"Morales","year":"2022","journal-title":"Psychiatr Ann"},{"issue":"4","key":"10.1016\/j.genhosppsych.2024.07.001_bb0125","doi-asserted-by":"crossref","first-page":"596","DOI":"10.15288\/jsad.2022.83.596","article-title":"Ethnoracial inclusion in clinical trials of ketamine in the treatment of mental health disorders","volume":"83","author":"Michaels","year":"2022","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1016\/j.genhosppsych.2024.07.001_bb0130","unstructured":"Health, N.I.o, Minority Health and Health Disparities: Definitions and Parameters."},{"issue":"8","key":"10.1016\/j.genhosppsych.2024.07.001_bb0135","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jash.2017.06.006","article-title":"White coat effect in hypertensive patients: the role of hospital environment or physician presence","volume":"11","author":"Wang","year":"2017","journal-title":"J Am Soc Hypertens"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834324001555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834324001555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T01:46:42Z","timestamp":1728352002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834324001555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":27,"alternative-id":["S0163834324001555"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2024.07.001","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood pressure changes during ketamine infusion for the treatment of depression","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2024.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}